Previous 10 | Next 10 |
2024-03-13 10:10:00 ET Summary Jeff Hirsch, editor-in-chief of The Stock Trader’s Almanac, and Carter Worth, CEO and founder of Worth Charting, discuss their outlook for 2024 with MoneyShow's Mike Larson. Jeff expects a strong year for stocks, with gains of 8-15% broadly sp...
2024-03-09 03:59:00 ET Summary Jared Ablass, Vice President, Portfolio Research at TD Asset Management, speaks with Greg Bonnell about how the biotech sector could benefit once rates start to come down. Why beaten down Biotech stocks could be ready for a healthy recovery. Biot...
2024-02-23 04:05:00 ET Summary Within healthcare, an area that has been negatively impacted the last couple of years is the pharmaceutical manufacturing value chain. Several capital goods and materials sectors experienced recessionary conditions last year, which caused weak fundam...
2024-02-18 00:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-02-07 01:53:00 ET Summary A sub-$3trn 2023 for M&A, but new year pipeline gives hope. Rising follow-on equity in 2023 signals latent appetite. Unstoppable debt capital markets hit $8.9trn for FY2023. By Lucille Jones, Senior Manager, Deals Intelligence and...
2024-02-04 08:05:00 ET Summary Bristol-Myers Squibb has faced revenue stagnation and a decline in stock price, but recent Q4 results suggest a potential rebound in top-line growth. BMY's in-line and new product portfolio showed strong sales growth, driven by top drugs like Eliquis...
Amphenol Corporation (NYSE: APH) announced today that its Board of Directors approved the first quarter 2024 dividend on its Common Stock in the amount of $0.22 per share at its meeting held on January 31, 2024. The Company will pay this first quarter 2024 dividend on April 10, 2024 to shareholde...
2024-01-31 04:36:00 ET Summary 2023 was characterized by narrow leadership and multiple expansions. While last year’s gains have led to headline valuations appearing stretched, there are many segments of the market that are not as aggressively priced. With the expectati...
Transaction highlights: To acquire Carlisle Interconnect Technologies for $2.0 billion in cash Adds leading capabilities in harsh environment interconnect solutions Broad product portfolio highly complementary to Amphenol’s existing interconnect solutions Accelerates lo...
Fourth Quarter 2023 Highlights: Record Sales of $3.33 billion, up 3% in U.S. dollars and down 1% organically compared to the fourth quarter of 2022 GAAP Diluted EPS of $0.83, up 1% compared to prior year Record Adjusted Diluted EPS of $0.82, up 5% compared to prior year ...
News, Short Squeeze, Breakout and More Instantly...
SPDR S&P Pharmaceuticals Company Name:
XPH Stock Symbol:
NYSE Market:
2024-07-19 12:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Transaction highlights: To acquire CommScope’s Outdoor Wireless Networks and Distributed Antenna Systems businesses for $2.1 billion in cash Adds advanced antenna and associated interconnect products, technologies and capabilities Complements Amphenol’s existing prod...
Amphenol Corporation (NYSE: APH) today announced it had completed the acquisition of the Carlisle Interconnect Technologies (CIT) business from Carlisle Companies Incorporated (NYSE: CSL). “The acquisition of CIT enhances Amphenol’s product offerings for highly engineered harsh ...